Style
Aggressive GrowthTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals Inc(MDGL) | 1,993,687 | $1.1B | 9.14% |
| 2 | Argenx SE(ARGX) | 709,446 | $658.2M | 5.62% |
| 3 | PTC Therapeutics Inc(PTCT) | 7,746,415 | $631.9M | 5.39% |
| 4 | Protagonist Therapeutics Inc(PTGX) | 5,061,175 | $620.4M | 5.30% |
| 5 | CG Oncology Inc(CGON) | 8,514,590 | $605.0M | 5.16% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 95% | 90.43% | -4.57% |
| Unclassified | 5% | 9.57% | +4.57% |
Quarter-over-quarter weight changes by market cap
| Insmed Inc(INSM) |
| 4,842,880 |
| $516.3M |
| 4.41% |
| 7 | Tango Therapeutics Inc(TNGX) | 13,900,620 | $434.5M | 3.71% |
| 8 | Spyre Therapeutics Inc(SYRE) | 4,251,996 | $377.5M | 3.22% |
| 9 | Celcuity Inc(CELC) | 3,304,903 | $345.8M | 2.95% |
| 10 | Erasca Inc(ERAS) | 17,946,754 | $328.8M | 2.81% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 50.91% | 47% | -3.91% |
| Large Cap | 30.03% | 25.6% | -4.43% |
| Small Cap | 13.07% | 16.84% | +3.77% |
| Unclassified | 5% | 9.57% | +4.57% |
| Micro Cap | 0.99% | 0.99% | 0% |
Quarter-over-quarter position changes